Road to Summit part 1: Vanessa Pott, Global head of Patient engagement at Boehringer Ingelheim (the Global Mental Health Community Summit (GMCS25) is here!)

As you all know I’m co-hosting the Global Mental Health Community Summit (GMCS25) this year again, and I’m so excited about it. This year’s event is focused on #RedefiningMentalHealthcareTogether. Boehringer Ingelheim has invited 60 of the most inspiring and motivated #mentalhealth advocates for three-days of connection, idea-sharing, and action towards meaningful change. It’s exciting!

I'm Struggling, And that's ok. (The Struggle Behind the Resilience: A Chronic Illness Journey)

I've been playing it cool for so long, standing on stages talking about resilience and overcoming illness. But the truth is, I'm struggling - struggling with my daily activities, my mental and emotional health, and even acclimating to a new city and country.

You're Paying Them For Your Health Data? It's Time to Flip the Script!

Hey Chronically crew! I'm back from a healthcare conference buzzing with talk about AI and the future of health data.But amidst all the flashy promises, something important is missing from the conversation: patient ownership. And it's making me mad. 😠

Your Emotional guiding Map in Illness

Living with chronic illness while pursuing a career can feel like an overwhelming challenge. As someone who has walked this path, I understand the unique hurdles you face. That's why I've created resources to help you thrive, both personally and professionally.

How to start a Patient Community

From a cancer researcher to a startup executive and all the way to starting er own Patient community about Inflammation based conditions. Dr. Natasha Punia and I are delving into a personal conversation about stigma, life with a chronic illness, being a chronic entrepreneur and channeling our pain into empowering others.

How can pharma work with patients?

I had the absolute pleasure to host Ursula Mann, a dear friend and colleague who served in senior patient engagement positions in big pharma for many years, to discuss bringing the voice of patients into industry decision-making, technology assessment, and more.